3Demots H.Glasser SP on behalf of the Transdermal Nitro Trial Study Group.Intermittlnt transdermal NTG therapy in the treatment of chronic stable angina[J].J Am CollCardiol,1989,13(4):786.
7Lgnarro L.Edwards J,Gruetter D Y,et al.Possible in volvement of S-nitrosothiols inthe activation of guanylate cyclase by nitrous compounds[J].FEBS Lett,1980,110(2):275.
8Mehra A,Shotan A,Ostrzega E,et al.Potentiation of isosorbide dinitrate effects withN-acetylcysteine in patients with chronic heart failure[J].Circulation,1994,89(12):2595.
9Munzel T,Sayegh H,Freeman B A,et al.Evidence for enhanced vascular superoxideanion production in nitrate tolerance.A novel mechanism underlying tolerance andcross-tolerance[J].J Clin Invest,1995,95(1):187.
1[1]Crandall L,Leake C,Loevenhart A,et al.A required tolerance to and cross-tolerance between the nitrous and nitricaid esters and sodium nitrite in man[J].J Pharmacol Exp Ther,1931,41:103
2[2]Packer M,Lee WH,Kessler PD,et al.Prevention and reversal of nitrate tolerance in patients with congestive heart failure[J].N Engl J Med,1987,317:799-804
4[4]Parker JD,Parker AB,Farrel B,et al.Effect of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina[J].Circulation,1996,93:691-696
5[5]Levy WS,Katz RJ,Ruffalo RL,et al.Potentiation of hemodynamic effects of acutely administered nitroglycerin by methionine[J].Circulation,1988,78:640-645
6[6]Boesgaard S,Aldershrile J,Enghusen H,et al.Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels[J].Circ Res,1994,74:115-120
7[7]Münzel T,Mülsh A,Holtz J,et al.Mechanism of interaction between the sulfhydryl precursor L-methionion and glyceryltrinitrate[J].Circulation,1992,86:995-1003
8[8]Katz RJ,Levy WS,Buff L,et al.Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors[J].Circulation,1991,83:1271-1277
9[9]Münzel T,Heitzer T,Kurz S,et al.Dissociation of coronary vascular tolerance and neurohomonal adjustment during long-term nitroglycerin therapy in patients with stable coronary artery disease[J].J Am Coll Cardiol,1996,27:297-303
10[10]Rajagopalan S,Kurz S,Münzel T,et al.Angiotensin Ⅱ-mediated hypertension via membrane NADH/NADHP oxidase activation:contribution to alteration of vasomotor tone[J].J Clin Invest,1996,97:1916-1923
5Panesar NS. Is steroid deficiency the cause of tolerance in nitrate therapy? Med Hypotheses,2000,55:310-313.
6Abrams J, Elkayam U,Thadami U, et al. Tolerance : A historical overview. Am J Cardiol, 1998,81:3A-14A.
7Gerzauich V, Ivanov A, Ivanova S, et al. Alternative splicing of cGMP-dependent protein kinase 1 in angiotensin-hypertension: nove 1 mechanism for nitrate tolerance in vascular smooth muscle. Circ Res,2003,93:805-812.
8Munzel T, Giaid A, Kurz S, et al. Evidence for a role of endothelin and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA, 1995,92:5244-5248.
9Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res, 2005,97:618-628.
10Sydow K, Daiber A, Oelze M, et al. Central role of mitochondrial aldehyde dehydr ogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest, 2004,113 : 482- 489.
